Effect of Ochratoxin A on a human haematopoietic progenitors proliferation and differentiation: An in vitro study

Human and Experimental Toxicology

Volumn 22, Issue 7, 2003, Pages 393-400

  Froquet, R ^a   Le Drean G ^a   Parent Massin, Dominique ^a  

^a TECHNOPÔLE BREST IROISE   (France)

Author keywords

Haematopoietic progenitors; Human; Myelotoxicity; Ochratoxin A

Indexed keywords

MYCOTOXIN; OCHRATOXIN; TRICHOTHECENE DERIVATIVE;

ACUTE TOXICITY; ARTICLE; BONE MARROW TOXICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ERYTHROBLAST; ERYTHROCYTE; FOOD CONTAMINATION; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERSTITIAL NEPHRITIS; LEUKOCYTE; LIVER TOXICITY; NEPHROTOXICITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; THROMBOCYTE; UMBILICAL CORD BLOOD;

CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; ERYTHROID PROGENITOR CELLS; HEMATOPOIESIS; HUMANS; MEGAKARYOCYTES; MYCOTOXINS; OCHRATOXINS;

ANIMALIA;

EID: 0042023769     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Vrabcheva T, Usleber E, Dietrich R, Martlbauer E. Cooccurrence of ochratoxin A and citrinin in cereals from Bulgarian villages with a history of Balkan endemic nephropathy. J Agric Food Chem 2000; 48: 2483-88.
2. Scudamore KA, Patel S, Breez V. Surveillance of stored grain from the 1997 harvest in the United Kingdom for ochratoxin A. Food Addit Contam 1999; 16: 281-90.
3. Romani S, Sacchetti G, Lopez CC, Pinnavaia GG, Dalla Rossa M. Screening on the occurrence of ochratoxin A in green coffee beans of different origins and types. J Agric Food Chem 2000; 48: 3616-19.
4. Leoni LA., Soares LM, Oliveira PL. Ochratoxin a in Brazilian roasted and instant coffees. Food Addit Contam 2000; 17: 867-70.
5. Domijan AM, Peraica M, Fuchs R, Lucic A, Radic B, Balija M, Bosanic I, Gogicevic D. Ochratoxin A in blood of healthy population in Zagreb. Arh Hig Rada Toksikol 1999; 50: 263-71.
6. Peraica M, Domijan AM, Fuchs R, Lucic A, Radic B. The occurrence of ochratoxin A in blood in general population of Croatia. Toxicol Lett 1999; 110: 105-12.
7. Otteneder H, Majerus P. Occurrence of ochratoxin A (OTA) in wines: influence of the type of wine and its geographical origin. Food Addit Contam 2000; 17: 793-98.
8. Thuvander A, Paulsen JE, Axberg K, Johansson N, Vidner A, Enghardt-Barkeri H, Tryg K, Lund-Larsen K, Jahrl S, Widerfalk A, Bosnes V, Alexander J, Holt K, Olsen M. Level of Ochratoxin A in blood from Norvegian and Swedish blood donors and their possible correlation with food consumption. Food Chem Toxicol 2001; 39: 1145-51.
9. Hald B. Ochratoxin A in human blood in European countries. IARC Sci Publ 1991; 115: 159-64.
10. Plestina R, Coevic S, Gatenbeck SS, Habazin-Novak V, Holt, K, Hokby E, Krogh P, Radic B. Human exposure to ochratoxin A in areas of Yugoslavia with endemic nephropathy. J Environ Toxicol Oncol 1990; 10: 145-48.
11. Bauer J, Gareis M. Ochratoxin A in der Nahrungsmittelkette. Z Veterinarmed B 1987; 34: 613-27.
12. Breitholtz A, Olsen M, Dahlback A, Hult K. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair technique. Food Addit Contam 1991; 6: 183-92.
13. Creppy EE, Betbeder AM, Gharbi A, Counord J. Human ochratoxicosis in France. In mycotoxins, endemic nephropathy and urinary tract. IARC Sci Publ 1991; 115: 145-51.
14. Creppy EE, Castegnaro M, Grosse Y, Mériaux J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirhemo G. Etude de l'ochratoxicose humaine dans trois regions de France: Alsace, Aquitaine et region Rhône-Alpes. In Creppy EE, Castegnaro M, Dirheimer G eds. Human ochratoxicosis and its pathologies John Libbey Eurotext INSERM 1993, 231: 167-74.
15. Kuiper-Goodman T, Ominski K, Marquardt RR, Malcom S. Estimating human exposure to ochratoxin A in Canada. In Creppy EE, Castegnaro M, Dirheimer G eds. Human ochratoxicosis and its pathologies John Libbey Eurotext INSERM 1993, 231: 147-58.
16. Kawamura O, Maki S, Sato S, Ueno Y. Ochratoxin A in livestock and human sera in Japan quantified by a sensitive ELISA. In Creppy EE, Castegnaro M, Dirheimer G eds. Human ochratoxicosis and its pathologies, John Libbey Eurotext INSERM 1993, 231: 159-65.
17. Filali A, Betbeder AM., Baudrimont I, Benayad A, Soulaymani R, Creppy EE. Ochratoxin A in human plasma in Morocco: a preliminary survey. Hum Exp Toxicol 2002; 21: 241-45.
18. Filastre JP. Experimental and human nephrotoxicity induced by ochratoxins. Bull Acad Nat Med 1997; 181: 1447-60.
19. Krogh P. Causal associations of mycotoxic nephropathy. Acta Pathol Microbiol Scand 1978; 269: 1-28.
20. Kane A, Creppy EE, Roschenthaler R, Dirheimer G. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 1986; 42: 233-43.
21. Huff WE, Wyatt RD, Tucker TL, Hamilton PB. Ochratoxicosis in the broiler chicken. Poult Sci 1974; 53: 1585-91.
22. Peckham JC, Doupnick B Jr, Jones OH Jr. Acute toxicity of ochratoxins A and B in chicks. Appl Microbial 1971; 21: 492-94.
23. Sczcech GM., Carlton WW, Tuite J. Ochratoxicosis in Beagle dogs. II. Pathology. Vet Pathol 1973; 11: 219-31.
24. Sczcech GM., Carlton WW, Tuite J, Caldwell R. Ochratoxin A toxicosis in swine. Vet Pathol 1973; 10: 347-64.
25. Parent-Massin D. Relevance of clonogenic assays in hematotoxicology. Cell Biol Toxicol 2001; 17: 87-94.
26. Lautraite S, Parent-Massin D, Rio B, Hoellinger H. Comparison of toxicity induced by T-2toxin on human and rat granulo-monocytic progenitors with an in vitro model. Hum Exp Toxicol 1995; 14: 672-78.
27. Rio B, Parent-Massin D. Improvement of erythroblastic progenitor culture for toxicological investigations. Toxicol Methods 1997; 7: 363-80.
28. Rio B, Froquet R, Parent-Massin D. In vitro effect of lead acetate on human erythropoietic progenitors. Cell Biol Toxicol 2001; 17: 41-50.
29. Froquet R, Sibiril Y, Parent-Massin D. Trichothecene toxicity on human megakaryocyte progenitors (CFU-MK). Hum Exp Toxicol 2001; 20: 84-89.
30. Van Den Heuvel RL., Leppens H. and Schoeters GE. Lead and catechol hematotoxicity in vitro using human and murine hematopoietic progenitor cells. Cell Biol Toxical 1999; 15: 101-10.
31. Van Den Heuvel RL., Leppens H, Schoeters GE. Use of in vitro assays to assess hematotoxic effects of environmental compounds. Cell Biol Toxicol 2001; 17 107-16.
32. Pessina A, Albella B, Bueren J, Brantom P et al. Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay. Toxicol In Vitro 2001; 15: 729-40.
33. Negro GD, Bonato M, Gribaldo L. In vitro bone marrow granulocyte-macrophage progenitor cultures in the assessment of hematotoxic potential of the new drugs. Cell Biol Toxicol 2001; 17: 95-105.
34. Gribaldo L, Casati S, Castoldi AF, Pessina A. Comparison of in vitro drugsensitivity of human granulocyte-macrophage progenitors from two different origins: umbilical cord blood and bone marrow. Exp Hematol 1999; 27: 1593-98.
35. Gribaldo L, Malerba I, Collotta A, Casati S et al. Inhibition of CFU-E/BFU-E by 3′-azido-3′-deoxythymidine, chlorpropamide, and protoporphirin IX zinc (II): a comparison between direct exposure of progenitor cells and long-term exposure of bone marrow cultures. Toxicol Sci 2000; 58: 96-101.
36. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
37. Gupta M, Bandyopadhyay S, Paul B, Majumder SK. Hematological changes produced in mice by ochratoxin A. Toxicology 1979; 14: 95-98.
38. Gupta M, Sasmal D, Bandyopadhyay S, Bagchi G, Chatterjee T, Dey S. Hematological changes produced in mice by ochratoxin A and citrmn. Toxicology 1983; 26: 55-62.
39. Boorman GA, Hong HL, Dieter MP, Hayes HT, Pohland E, Stack M, Luster MI. Myelotoxicity and macrophage alteration in mice exposed to ochratoxin A. Toxicol Appl Pharmacol 1984; 72: 304-12.
40. Huong HHL, Jameson CW, Boorman GA. Residual hematopoietic effect in mice exposed to ochratoxin A prior to irradiation. Toxicology 1988; 53: 57-67.
41. NTP. NTP technical report on the toxicology and carcinogenesis studies of ochratoxin A (CAS NO. 303-47-9) in F3441N rats (gavage studies). Boorman G ed. NIH publication No. 88-2813 Research triangle Park, NC: U.S. Department of health and Human services National Institutes of Health, 1989.
42. Kuiper-Goodman T, Grant DL. Ochratoxin A (WHO Food Additives Series 28). Joint Expert Committee on Food Additives (JECFA). Thirty seventh committee, 1990.
43. Creppy EE, Kane A, Giessen-Crouse E, Roth A, Roscheuthaler R, Dirheimer G. Effect of ochratoxin A on enzyme activities and macromolecules synthesis in MDCK cells. Arch Toxicol 1986; 9: 310-14.
44. Baudrimont I, Betbeder AM, Creppy EE. Reduction of the ochratoxin A-induced cytotoxicity in Vero cells by aspartame. Arch Toxicol 1997; 71: 290-98.
45. Creppy EE, Roschenthaler R, Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem Toxicol 1984; 22: 883-86.
46. Huff WE, Chang CF, Warren MF, Hamilton PB. Ochratoxin A-induced iron deficiency anemia. Appl Environ Microbiol 1979; 37: 601-604.
47. Harvey RB, Kubena LF, Elissalde MH, Rottinghaus GE. Administration of ochratoxin A and T-2 toxin to growing swine. Am J Vet Res 1994; 55: 1757-61.
48. Bailey CA, Gibson RM, Kubena LF, Huff WE et al. Ochratoxin A and dietary protein. 2.Effects on hematology and various clinical chemistry measurements. Poult Sci 1989; 68: 1664-71.
49. Bailey CA, Gibson RM, Kubena LF, Huff WE et al. Impact of L-phenylalanine supplementation on the performance of three-week-old broilers fed diets containing ochratoxin A. 2. Effects on hematology and clinical chemistry. Poult Sci 1990; 69: 420-25.
50. Lautraite S, Parent-Massin D, Rio B, Hoellinger H. In vitro toxicity induced by deoxynivalenol (DON) on human and rat granulo-monocytic progenitors. Cell Biol Toxicol 1997; 13: 175-83.
51. Rio B, Lautraite S, Parent-Massin D. In vitro toxicity of trichothecenes on human erythroblastic progenitors. Hum Exp Toxicol 1997; 16: 673-79.